AstraZeneca

Open: 72.55 Close: 72.52 Change: -0.03

Stop reading the whole internet to decide if you want to invest in AstraZeneca.

Are looking for the most relevant information about AstraZeneca? Investor spend a lot of time searching for information to make investment decisions in AstraZeneca. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, Astrazeneca, company, PE, Ratio, Astra, Information, and the most common words in the summary are: astrazeneca, news, cancer, astrazenecas, stock, new, covid19, . One of the sentences in the summary was: Average price target for AstraZeneca is $79.00, which is 8.94% higher than the current …

Concept Map

Semantic Network

Stock Summary

AstraZeneca PLC focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa,.

Today's Summary

Astrazeneca is the sixth-largest pharmaceutical company in the world. Average price target for AstraZeneca is $79.00, which is 8.94% higher than the current price. CEO Pascal Soriot says company is looking for ‘modest profitability” on its covid-19 vaccines.

Today's News

AstraZeneca Information Center in the U.S. is staffed 24 hours daily/7 days a week. Healthcare professionals may also visit our HCP Medical Information page. Astrazeneca is the sixth-largest pharmaceutical company in the world and the second-biggest international-based drugmaker behind Novartis. With a $228 billion market capitalization, AstraZeneca is sixth largest pharmaceutical company. AstraZeneca PE Ratio: 48.03 for May 26, 2023 PE Ratio Chart Historical PE Ratio Data View and export this data back to 1993. Ultomiris gets approval for a new rare disease indication in the EU. Astrazeneca has 3.10 billion shares outstanding. Average price target for AstraZeneca is $79.00, which is 8.94% higher than the current price. Dividend per share is $2.39, earnings are 2.09% and FCF is 4.03%. AstraZeneca CEO Pascal Soriot says company is looking for “modest profitability” on its covid-19 vaccines. The vaccine, he added, “will never be high-priced. Because we want the vaccine to remain affordable to everybody around the world” AstraZeneca Egypt has been a leading advocate for sustainability in the region. At COP27 last year, Astra Zeneca Egypt announced several programs to accelerate the decarbonisation of healthcare and the establishment of green hospitals in the country. Astra has also invested in decarbonising its supply chain, by shifting supply routes from air to sea. AstraZeneca plc (azn) is lower by 1.71% wed Wednesday in premarket trading. Astra has the 34th highest Short-Term Technical score. Astrazeneca are transforming the future of healthcare. AstraZeneca has supported the #WorldHeartSummit 2023. Healthy Heart Africa aims to reach 10 million people with elevated blood pressure. AstraZeneca hires LSEG CFO Anna Manz as non-executive director from September 1. Total Revenue excluding COVID-19 medicines increasing 15%. New AstraZeneca data presented at ATS 2023 Strengthen the Body of Evidence Supporting Early Intervention With BREZTRI in COPD.

Stock Profile

"AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom."

Keywords

This document will help you to evaluate AstraZeneca without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, Astrazeneca, company, PE, Ratio, Astra, Information, and the most common words in the summary are: astrazeneca, news, cancer, astrazenecas, stock, new, covid19, . One of the sentences in the summary was: Average price target for AstraZeneca is $79.00, which is 8.94% higher than the current price. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #astrazeneca #news #cancer #astrazenecas #stock #new #covid19.